Latest Articles

Publication Date
'The only one that’s ever worked': Pill funding welcomed by endometriosis patient - Bay of Plenty Times

'The only one that’s ever worked': Pill funding welcomed by endometriosis patient Bay of Plenty Times

Published: March 16, 2025, 4:03 p.m.
New endometriosis pill could 'transform' treatment' - but only for some patients - Surrey Live

New endometriosis pill could 'transform' treatment' - but only for some patients Surrey Live

Published: March 16, 2025, 6 a.m.
New NHS-approved endometriosis pill - but only for some patients - Express

New NHS-approved endometriosis pill - but only for some patients Express

Published: March 16, 2025, 6 a.m.
A New Pill Will Soon Be Available For Endometriosis Patients – Here’s What You Should Know - British Vogue

A New Pill Will Soon Be Available For Endometriosis Patients – Here’s What You Should Know British Vogue

Published: March 14, 2025, 11:16 a.m.
Endometriosis patient reacts to new pill approval - BBC.com

Endometriosis patient reacts to new pill approval BBC.com

Published: March 13, 2025, 6:38 p.m.
Endometriosis patient reacts to new pill approval - BBC

Endometriosis patient reacts to new pill approval BBC

Published: March 13, 2025, 6:38 p.m.
West Coast Endometriosis Patient Trying to “Get the Conversation Going” While Raising Funds for EndoFound - Endometriosis Foundation of America - The Blossom

West Coast Endometriosis Patient Trying to “Get the Conversation Going” While Raising Funds for EndoFound Endometriosis Foundation of America - The Blossom

Published: March 13, 2025, 4:26 p.m.
New endometriosis pill approved for NHS use, but only few patients will benefit - Pharmacy Business

New endometriosis pill approved for NHS use, but only few patients will benefit Pharmacy Business

Published: March 13, 2025, 12:10 p.m.
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire

Published: March 12, 2025, 5:34 p.m.
Doctors Sue HHS for Removing Patient Safety Papers - Medpage Today

Doctors Sue HHS for Removing Patient Safety Papers Medpage Today

Published: March 12, 2025, 4:31 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!